FIELD: medicine.
SUBSTANCE: group of inventions relates to method for preventing or treating recurrent middle ear acute otitis, arising as result of Streptococcus pneumoniae infection in patients risk group, involving administering therapeutically effective amount of composition, at least once, to patient. Added composition contains at least one immunogenic polypeptide chosen from group consisting of polypeptides S. pneumoniae PhtD, PhtE, PcpA, LytB and deactivated pneumolysin.
EFFECT: declared group of inventions has effective protective action.
37 cl, 6 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PURIFYING BACTERIAL CYTOLYSIN | 2004 |
|
RU2340627C2 |
| IMMUNOBIOLOGICAL AGENT BASED ON RECOMBINANT PROTEIN FOR PREVENTING PNEUMOCOCCAL INFECTION | 2024 |
|
RU2823752C1 |
| VACCINES AND COMPOSITION AGAINST STREPTOCOCCUS PNEUMONIAE | 2012 |
|
RU2623174C2 |
| STREPTOCOCCUS PNEUMONIAE VACCINES AND COMPOSITIONS | 2010 |
|
RU2580299C2 |
| COMBINATIONS CONTAINING SEROTYPE 14 PNEUMOCOCCAL SACCHARIDE | 2010 |
|
RU2549438C2 |
| COMBINATIONS OF MENINGOCOCCAL FACTOR-H-BINDING PROTEIN AND PNEUMOCOCCAL SACCHARIDE CONJUGATES | 2010 |
|
RU2555757C2 |
| POLYVALENT PNEUMOCOCCAL VACCINES | 2019 |
|
RU2815390C2 |
| STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | 2015 |
|
RU2688831C2 |
| COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSTICS OF CHLAMYDIA INFECTION | 2001 |
|
RU2410394C2 |
| STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | 2015 |
|
RU2743793C1 |
